• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人白细胞介素2的F42A突变体的溶液结构

The solution structure of the F42A mutant of human interleukin 2.

作者信息

Mott H R, Baines B S, Hall R M, Cooke R M, Driscoll P C, Weir M P, Campbell I D

机构信息

Glaxo Research & Development Ltd., Medicines Research Centre, Stevenage, Hertfordshire, U.K.

出版信息

J Mol Biol. 1995 Apr 14;247(5):979-94. doi: 10.1006/jmbi.1994.0194.

DOI:10.1006/jmbi.1994.0194
PMID:7723044
Abstract

Interleukin 2 (IL-2) is one of the major cytokines produced by T lymphocytes in response to antigen. It is a potent growth and differentiation factor for several cell-types and is structurally related to the four-helix bundle family of cytokines. Mutation of residue Phe42 to Ala abolishes binding to the alpha chain of the tri-partite IL-2 receptor. The three-dimensional structure of the F42A mutant IL-2 has been calculated by two dimensional NMR methods and compared to a structure of wild-type IL-2 determined by X-ray crystallography. The overall topology of the two structures is the same. The main differences between the structures are within the ill-defined loops connecting the helices and the region of the protein that is believed to interact with the alpha-chain of the receptor. Thus, the mutation of Phe42 to Ala does not perturb the overall three-dimensional structure of IL-2, and does not appear to change the putative binding sites for the beta and gamma chains of the receptor. The structural differences observed in this mutant suggest that the replacement of Phe42 with Ala causes the re-orientation of neighbouring side-chains that are also involved in binding the alpha-chain of the receptor.

摘要

白细胞介素2(IL-2)是T淋巴细胞在对抗抗原时产生的主要细胞因子之一。它是几种细胞类型的强效生长和分化因子,在结构上与细胞因子的四螺旋束家族相关。将第42位残基苯丙氨酸(Phe)突变为丙氨酸(Ala)会消除与三方IL-2受体α链的结合。已通过二维核磁共振方法计算出F42A突变体IL-2的三维结构,并与通过X射线晶体学确定的野生型IL-2结构进行了比较。两种结构的整体拓扑相同。结构之间的主要差异在于连接螺旋的不明确环内以及被认为与受体α链相互作用的蛋白质区域。因此,将Phe42突变为Ala不会扰乱IL-2的整体三维结构,并且似乎不会改变受体β链和γ链的假定结合位点。在该突变体中观察到的结构差异表明,用Ala取代Phe42会导致也参与结合受体α链的相邻侧链重新定向。

相似文献

1
The solution structure of the F42A mutant of human interleukin 2.人白细胞介素2的F42A突变体的溶液结构
J Mol Biol. 1995 Apr 14;247(5):979-94. doi: 10.1006/jmbi.1994.0194.
2
Three-dimensional solution structure and backbone dynamics of a variant of human interleukin-3.人白细胞介素-3变体的三维溶液结构与主链动力学
J Mol Biol. 1996 Jun 14;259(3):524-41. doi: 10.1006/jmbi.1996.0337.
3
Human interleukin-4 and variant R88Q: phasing X-ray diffraction data by molecular replacement using X-ray and nuclear magnetic resonance models.人白细胞介素-4及其R88Q变体:利用X射线和核磁共振模型通过分子置换对X射线衍射数据进行相位分析。
J Mol Biol. 1995 Mar 24;247(2):360-72. doi: 10.1006/jmbi.1994.0144.
4
Unexpected effects of the IL-2 receptor alpha subunit on high affinity IL-2 receptor assembly and function detected with a mutant IL-2 analog.用突变型白细胞介素-2类似物检测白细胞介素-2受体α亚基对高亲和力白细胞介素-2受体组装及功能的意外影响。
J Immunol. 1993 Apr 15;150(8 Pt 1):3357-65.
5
Folding topologies of human interleukin-6 and its mutants as studied by NMR spectroscopy.通过核磁共振光谱学研究人白细胞介素-6及其突变体的折叠拓扑结构。
Biochemistry. 1996 Jan 9;35(1):273-81. doi: 10.1021/bi951949e.
6
Substitutions at the Glu62 residue of human interleukin-2 differentially affect its binding to the alpha chain and the beta gamma complex of the interleukin-2 receptor.人白细胞介素-2的Glu62残基处的替换对其与白细胞介素-2受体的α链和βγ复合体的结合有不同影响。
Eur J Immunol. 1995 May;25(5):1212-6. doi: 10.1002/eji.1830250512.
7
Analysis of the solution structure of human interleukin-4 determined by heteronuclear three-dimensional nuclear magnetic resonance techniques.
J Mol Biol. 1994 Apr 22;238(1):23-41. doi: 10.1006/jmbi.1994.1265.
8
Solution structure of recombinant human interleukin-6.重组人白细胞介素-6的溶液结构
J Mol Biol. 1997 May 2;268(2):468-81. doi: 10.1006/jmbi.1997.0933.
9
The solution structure of bovine ferricytochrome b5 determined using heteronuclear NMR methods.使用异核核磁共振方法测定的牛高铁细胞色素b5的溶液结构。
J Mol Biol. 1996 Apr 26;258(1):172-89. doi: 10.1006/jmbi.1996.0241.
10
Structure of the quaternary complex of interleukin-2 with its alpha, beta, and gammac receptors.白细胞介素-2与其α、β和γc受体的四元复合物结构。
Science. 2005 Nov 18;310(5751):1159-63. doi: 10.1126/science.1117893.

引用本文的文献

1
Anti-cancer effect of interleukin-2 fused to flagellin expressed by tumor-targeting Salmonella.肿瘤靶向性沙门氏菌表达的鞭毛蛋白融合白细胞介素-2的抗癌作用
Oncogene. 2025 Jul 24. doi: 10.1038/s41388-025-03504-y.
2
Selectivity of bovine interleukin-2 mutein stimulation on bovine peripheral blood mononuclear cells.牛白细胞介素-2突变体对牛外周血单个核细胞刺激的选择性
J Vet Med Sci. 2025 Jul 7;87(7):781-790. doi: 10.1292/jvms.24-0470. Epub 2025 May 30.
3
Novel anti-CD73-IL-2v bispecific fusion protein augments antitumor immunity by alleviating immunosuppressive adenosine pathways in CD8 T cells.
新型抗CD73-IL-2v双特异性融合蛋白通过减轻CD8 T细胞中的免疫抑制腺苷途径增强抗肿瘤免疫力。
J Immunother Cancer. 2025 Mar 13;13(3):e008594. doi: 10.1136/jitc-2023-008594.
4
Efficacy and antitumor activity of a mutant type of interleukin 2.一种突变型白细胞介素 2 的疗效和抗肿瘤活性。
Sci Rep. 2022 Mar 30;12(1):5376. doi: 10.1038/s41598-022-09278-7.
5
Selective delivery of low-affinity IL-2 to PD-1+ T cells rejuvenates antitumor immunity with reduced toxicity.低亲和力 IL-2 的选择性递送可降低毒性,使 PD-1+ T 细胞的抗肿瘤免疫恢复活力。
J Clin Invest. 2022 Feb 1;132(3). doi: 10.1172/JCI153604.
6
Fine-tuned long-acting interleukin-2 superkine potentiates durable immune responses in mice and non-human primate.经过微调的长效白细胞介素-2 超激动剂可增强小鼠和非人灵长类动物的持久免疫应答。
J Immunother Cancer. 2022 Jan;10(1). doi: 10.1136/jitc-2021-003155.
7
MK-6, a novel not-α IL-2, elicits a potent antitumor activity by improving the effector to regulatory T cell balance.MK-6,一种新型非-α IL-2,通过改善效应器对调节性 T 细胞的平衡来发挥强大的抗肿瘤活性。
Cancer Sci. 2021 Nov;112(11):4478-4489. doi: 10.1111/cas.15127. Epub 2021 Sep 23.
8
Next-generation cytokines for cancer immunotherapy.用于癌症免疫治疗的新一代细胞因子。
Antib Ther. 2021 Jun 25;4(2):123-133. doi: 10.1093/abt/tbab014. eCollection 2021 Apr.
9
Cytokines that target immune killer cells against tumors.靶向免疫杀伤细胞对抗肿瘤的细胞因子。
Cell Mol Immunol. 2020 Jul;17(7):722-727. doi: 10.1038/s41423-020-0481-0. Epub 2020 Jun 10.
10
Neoleukin-2 enhances anti-tumour immunity downstream of peptide vaccination targeted by an anti-MHC class II VHH.神经白细胞素-2 增强了针对 MHC Ⅱ类 VHH 靶向肽疫苗的抗肿瘤免疫。
Open Biol. 2020 Feb;10(2):190235. doi: 10.1098/rsob.190235. Epub 2020 Feb 5.